On March 15, 2019, Oncodia entered an exclusive, worldwide agreement with Temasek Life Science Laboratories, Singapore (TLL), on the commercialization of TLL’s patented PBR pattern recognition technology for DNA and…

Following the Seed Round, the Board of Directors has been extended with senior expertise in medical device commercialization. Erik Hedlund, Chairman of Nolsterby Invest AB, is the Chairman of Oncodia.…

In a competitive call for supporting product development and accelerating market launch, Oncodia has been was awarded an EIT Health Headstart grant of €50.000. The project will speed the development…

Oncodia raised MSEK 4 on May 15, 2019 from private and public investors to support development and market launch of its regulatory compliant software for mutation diagnostics in cancer. The…